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188 The Journal of Thoracic and Cardbjective: This review evaluates the outcome of a treatment strategy using dual-
hamber pacemakers for neonates with congenital heart block.
ethods: From 1989 to 2006, 10 neonates had dual-chamber epicardial pacemaker
lacement for congenital heart block. Mean age and weight were 4.4 5.6 days and
.8  0.6 kg. Four patients had heterotaxy syndrome and required concomitant
ardiac procedures. One patient had fetal hydrops, myocarditis, and cardiomyopa-
hy. Five patients had structurally normal hearts. Sternotomy (2 partial, 8 full) and
nipolar leads (2 non–steroid eluting, 18 steroid-eluting) were used in all. Gener-
tors were placed in submuscular bilateral rectus sheath pockets.
esults: Successful atrioventricular synchrony was established in all patients. Mean
-wave sensing was 4.7  2.6 mV and atrial voltage threshold was 0.8  0.3 V.
ean R-wave sensing was 13.0  5.7 mV and ventricular voltage threshold 0.9 
.5 V. There were no wound complications or acute lead failures. Median postop-
rative stay was 14 days. Three of the 4 patients with heterotaxy died at 3 days, 14
ays, and 15 months postoperatively. The patient with cardiomyopathy died sud-
enly at 6 months of acute myocarditis. No patient with a structurally normal heart
ied (P  .05). Mean follow-up interval in survivors is 6.1  7.1 years with 1
atient lost to follow-up.
onclusions: Implantation of a dual-chamber epicardial pacemaker in neonates with
ongenital heart block is technically feasible and results in excellent outcomes in
atients with structurally normal hearts. System longevity at 6 years is excellent.
atients with congenital heart block and heterotaxy syndrome have a poor prognosis
espite dual-chamber pacing.
ongenital complete heart block (CHB) is a rare conduction anomaly occur-
ring in 1/11,000 to 1/20,000 live births.1 It is defined as atrioventricular
block “diagnosed in utero, at birth, or in the first month of life.”2 Histori-
ally, neonates with CHB have been separated into three primary groups.1 In the
rst group, CHB is associated with maternal connective tissue disease. The most
ommon association is with maternal systemic lupus erythematosus.3 Maternal
ntibodies begin circulating through the fetus in the mid-second trimester and affect
he myocardium, particularly conducting tissue, leading to fibrous replacement of
he tissue.1,4 In the second group, heart block is associated with other cardiac
efects, most commonly left atrial isomerism; it is thought that discontinuity
etween the atrioventricular node and the ventricular conduction tissues results in
eart block.1 Thirty percent of all patients with CHB are in this group.5 The third
nd smallest group, up to 10%, consists of neonates with seronegative isolated
HB.1
Previous studies have reported mortality rates for isolated CHB ranging from
1% to 45%.1 Mortality rates for CHB with heterotaxy syndrome are much higher
iovascular Surgery ● November 2007
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Dnd were reported at 100% in a recent study from Toronto.6
elayed pacing therapy or hemodynamic compromise from
ssociated cardiac defects results in early death according to
ost series.7
We began implanting single-lead, epicardial ventricular
acemakers for neonatal CHB in 1971, as reported by Idriss
nd associates in 1973.8 Dual-chamber pacemakers were
oo cumbersome for neonatal use, and atrial leads func-
ioned poorly at that time. However, advances in pacemaker
echnology (smaller hardware and longer battery life) have
llowed the advantages of dual-chamber pacing, such as
trioventricular synchrony and sinus node responsiveness,
o outweigh the drawbacks of a larger device and the need
or two leads. The use of steroid-eluting epicardial leads
llowed for successful atrial lead placement.9 We have
mplanted dual-chamber epicardial pacemakers for CHB for
he past 17 years. The purpose of this review is to evaluate
he outcome of that treatment strategy.
aterials and Methods
he Institutional Review Board at Children’s Memorial Hospital,
hicago, Illinois, approved this retrospective study and granted a
aiver of informed consent on October 25, 2005.
We identified 10 patients from our computerized cardiovascu-
ar database who underwent neonatal surgical implantation of a
ual-chamber epicardial pacemaker for CHB between February
989 and January 2006. There were 4 boys and 6 girls with a mean
ge of 4.4 5.6 days (range 1–19 days) and mean weight of 2.8
.6 kg (range 2.0-4.2 kg). The medical records of all patients were
eviewed. Cardiac diagnosis, operative technique, concomitant
ardiac procedures at pacemaker implant, and patient age and
tatus at follow-up were reviewed. Data collected included pace-
aker programming data and later pacemaker or lead interventions
ncluding replacements or upgrades, as well as cause for
ntervention.
There were 4 additional neonatal patients with CHB treated at
ur institution during the above-noted time period. One patient
ith CHB was transferred to our institution on day 9 after birth in
xtremis. The child was supported by an oscillator ventilator and
igh-dose pressors. A temporary ventricular lead was placed at the
edside. The child died of anasarca and coagulopathy 2 days later.
ne patient in 1991, who weighed 2.9 kg at birth, had placement
f a VVI pacemaker at 4 days of age. That patient had elective
enerator replacement at 5 years of age and was then lost to
ollow-up. There were 2 other neonates with CHB who were not
reated with a pacemaker at birth (1990, 1991).
Five patients had isolated CHB with structurally normal hearts.
f this group, 1 patient’s mother tested positive for Sjögren
yndrome, 1 patient had a family history of lupus, and 3 patients’
Abbreviations and Acronyms
CHB congenital heart block
DDD dual-chamber pacingothers tested negative for lupus. Four of the other 5 patients had t
The Journal of Thoracicigure 1. Dual-chamber pacing leads as placed through a full
ternotomy. The steroid-eluting leads are directly affixed to the
picardium with two 5-0 polypropylene sutures.igure 2. A pocket for the pacemaker is created beneath both
ectus muscles. Through a midline incision extending nearly to
he umbilicus, bilateral subcutaneous flaps are created, allowing
obilization of the anterior rectus sheath. The anterior rectus
heath is entered on either side of the linea alba. This opening is
xtended vertically to free up the anterior rectus sheath. Next, the
ectus muscle is dissected off the posterior rectus sheath. The
acemaker is implanted just above the posterior rectus sheath.
he peritoneum is not entered. The rectus muscles are reapproxi-
ated in the midline with interrupted polyglactin sutures (Vicryl;
thicon, Inc, Johnson & Johnson, New Brunswick, NJ), providing
muscular padding for the pacemaker. The subcutaneous layer is
pproximated with running polyglactin and the skin with subcu-
icular polydioxanone or interrupted nylon.
and Cardiovascular Surgery ● Volume 134, Number 5 1189
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Dtructurally abnormal hearts associated with heterotaxy syndrome
3 polysplenia, 1 asplenia). One other patient had fetal hydrops,
trial flutter, and ventricular tachycardia diagnosed in utero, with
yocarditis and cardiomyopathy diagnosed postnatally.
A partial sternotomy approach was used in the first 2 patients
nd a full sternotomy in the last 8 patients. The first patient
eceived two non–steroid eluting unipolar epicardial leads, Oscor
odel MP35V (Oscor Inc, Palm Harbor, Fla). All subsequent
atients received 25-cm steroid-eluting unipolar leads, Medtronic
odels 10295B (1 patient) and 4965 (8 patients) (Medtronic, Inc,
inneapolis, Minn). Each lead was sutured to the epicardial sur-
ace with two interrupted 5-0 polypropylene sutures (Figure 1).
he ventricular lead was placed in the high right ventricular
utflow tract. Atrial lead placement was in the midportion of the
ight atrium to avoid stimulation of the phrenic nerve. The pace-
aker generator was placed in a submuscular bilateral rectus
heath pocket as previously reported.10 The rectus muscle and
nterior rectus sheath were brought together in the midline (Figure
). In the neonate, the size of the pacemaker generator prevents
lacement of the device under only one or the other rectus muscle
Figure 3). Various models of dual-chamber pacemaker generators
ere used over time, including Intermedics Cosmos II 284-05
now Guidant Corp, Indianapolis, Ind), and Medtronic models
igure 3. Babygram in a 2.2-kg infant shows the typical postop-
rative appearance after placement of a dual-chamber epicardial
acemaker. The left pleural space has been drained by a left
hest tube. The right pleural space and mediastinum are drained
y a chest tube passed through the right pleural space. The
entricular lead is on the high right ventricular outflow tract.
oils of the lead are placed within the pericardium to allow for
rowth. In a similar fashion, a coil is placed within the pace-
aker pocket. The size of the dual-chamber pacemaker in com-
arison to the baby is quite evident, illustrating the need for
mplantation beneath both rectus muscles.hera DR 7960, Thera DR 7968, Kappa DR KDR921, EnPulse DR e
190 The Journal of Thoracic and Cardiovascular Surgery ● Nov1DR21, and EnPulse DR E2DR21. Successful atrioventricular
ynchrony was established in all patients after pacemaker
lacement.
Data were compared with the Fisher exact test using StatView
tatistical software (SAS Institute Inc, Cary, NC). Two-tailed P
alues are reported.
esults
uccessful atrioventricular synchrony was established in all
atients. Excellent pacing and sensing thresholds were ob-
ained, as illustrated in Table 1. Atrial leads had a mean
-wave sensing of 4.7 2.6 mV with a voltage threshold of
.8  0.3 V. Ventricular leads had a mean R-wave sensing
f 13.0  5.7 mV with a voltage threshold of 0.9  0.5 V.
edian postoperative stay was 14 days. There were no
ound complications or early lead failures. Three of the 4
atients with heterotaxy died at 3 days, 14 days, and 15
onths postoperatively. The patient with cardiomyopathy
ied suddenly at 6 months of acute myocarditis. The clinical
haracteristics of the 4 patients who died are shown in Table
. Autopsy findings were available for all deceased patients.
o patients with structurally normal hearts died (P  .05).
ean follow-up interval in survivors is 6.1  7.1 years
range 0.2-16.8 years) with 1 patient lost to follow-up.
One patient with CHB and heterotaxy syndrome (asple-
ia, dextrocardia) is alive at current follow-up. At 2 days of
ge she had pacemaker placement via sternotomy followed
mmediately by coarctation repair via right thoracotomy.
he underwent partial atrioventricular canal repair at 9
onths of age and is doing well 10 months later.
Three of 6 surviving patients have undergone lead revi-
ion. Mean interval to first lead revision is 5.5  3.4 years,
ith a range of 1.7 to 7.1 years. In all 3 cases the indication
or revision was ventricular lead fracture. The same 3 pa-
ients underwent pacemaker generator change at the time of
ead revision; one of these patients had also undergone a
rior generator change. Mean interval to first generator
hange is 4.3  2.7 years, with a range of 1.7 to 7.1 years.
he patient with two generator changes, at 4 years and 7
ears, has subsequently had conversion to a transvenous
ystem at 14 years. At last follow-up, all patients remain in
DD pacing mode with atrioventricular synchrony. There
as been no atrial lead failure.
iscussion
hen the late Dr Farouk S. Idriss first reported our expe-
ience implanting single-lead, epicardial ventricular pace-
akers for neonatal CHB in 1973, he stated that, “Pacing
ontrolled by the atrial rate may be the solution. However,
t present, these pacemakers are too cumbersome for im-
lantation in infants.”8 Advances in pacemaker technology
ave led to smaller hardware and better battery life, leading
o the technical feasibility of DDD pacing. The steroid-
luting epicardial lead developed by Medtronic was another
ember 2007
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Dechnologic leap that made dual-chamber pacing possible,
articularly atrial pacing.9,11 We have implanted dual-
hamber epicardial pacemakers for CHB for the past 17
ears.
Advantages of dual-chamber pacing include sinus node
esponsiveness and maintaining physiologic atrioventricular
ynchrony. Karpawich and associates12 compared physio-
ogic response of VVI versus DDD pacing in 8 pediatric
atients with nonsurgical atrioventricular block in 1987.
his report showed that although both pacing modes al-
owed ventricular rate to increase with exercise, VVI mode
ABLE 1. Patient characteristics and pacing parameters
atient Diagnosis
P w
(m
1 Isolated CHB 2
2 Isolated CHB 2
3 CHB, fetal hydrops, myocarditis,
cardiomyopathy
3
4 Isolated CHB 8
5 Isolated CHB 4
6 CHB, heterotaxy syndrome (polysplenia);
complete AVC, COA
2
7 CHB, heterotaxy syndrome (polysplenia);
VSD, common atrium, bilateral PDA,
bilateral SVC
4
8 CHB, heterotaxy syndrome (polysplenia);
DORV, pulmonary stenosis, ventricular
non-compaction
9
9 CHB, heterotaxy syndrome (asplenia
with midline liver); unbalanced AVC,
COA, dextrocardia
3
10 Isolated CHB 8
Mean  SD 4.7 
P-VP, Percentage of time pacemaker is performing atrial pacing and ventr
nd ventricular pacing; AVC, atrioventricular canal; CHB, congenital com
entricle; PDA, patent ductus arteriosus; SD, standard deviation; SVC, sup
ABLE 2. Clinical characteristics of patients with CHB wh
atient
Age at pacemaker
implantation Diagnosis
1 2 d Myocarditis, cardiomyopathy,
ventricular tachycardia
2 1 d Heterotaxy (polysplenia), unba
AVC, coarctation of the aort
3 2 d Heterotaxy (polysplenia), VSD,
bilateral PDA, SVC, LVOT
obstruction
4 3 d Heterotaxy (polysplenia), DORV
severe PS, PDA (PGE1)
SD, Atrial septal defect; AVC, atrioventricular canal; CHB, congenital co
utflow tract; PDA, patent ductus arteriosus; PGE1, prostaglandin E1, PS, pulmo
The Journal of Thoracicas associated with ectopy and greater risk for sudden
eath. The study also found hemodynamic benefits of DDD
acing while at rest for patients with complete atrioventric-
lar block. Patients in DDD mode exhibited slower resting
inus rates as well as increases in stroke volume, shortening
raction, and cardiac output compared with those exhibited
ith VVI pacing.
Arguments against dual-chamber epicardial pacing in
eonates with CHB include technical difficulty and atrial
ead complications.13,14 Our experience and reports of oth-
rs clearly demonstrate the technical feasibility of this strat-
Atrial
threshold (V)
R wave
(mV)
Ventricular
threshold (V) AS-VP/AP-VP
0.6 16.5 0.8 100%/0%
14 96%/4%
0.5 23.4 0.7 No information
0.5 11 1.8 100%/0%
9.8 0.2 100%/0%
1 11 0.5 8%/92%
1.4 8 1.2 50%/50%
0.6 5.4 0.7 99%/1%
0.8 10 1.3 0%/100%
0.7 21 0.6 100%/0%
0.8  0.3 13  5.7 0.9  0.5
pacing; AS-VP, percentage of time pacemaker is performing atrial sensing
heart block; COA, coarctation of the aorta; DORV, double-outlet right
vena cava; VSD, ventricular septal defect.
ed
Other Procedures Age at death Cause of death
6 mo Sudden death,
acute
myocarditis
d Coarctation (5 d),
AVC, Glenn, 6 mo
15 mo Necrotizing
enterocolitis
VSD closure, LVOT
tract surgery (3 d)
5 d Renal failure,
low cardiac
output
Blalock–Taussig
shunt (3 d)
17 d Anasarca,
sepsis
te heart block; DORV, double-outlet right ventricle; LVOT, left ventricularave
V)
.6
.8
.5
2.6
icular
pleteo di
lance
a
ASD
mple
nary stenosis; SVC, superior vena cava; VSD, ventricular septal defect.
and Cardiovascular Surgery ● Volume 134, Number 5 1191
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Dgy.13 We had no incidence of atrial lead fracture or failure
n this small series. Outcomes were excellent, 100% sur-
ival, in patients with structurally normal hearts. Further-
ore, all patients remain in DDD mode with atrioventricu-
ar synchrony at a mean follow-up of 6.1 years from the date
f surgery.
The high mortality rate of patients with CHB and struc-
urally abnormal hearts in our series (4/5 patients, 80%) is
onsistent with reports in the literature.1,6,15 Berg and col-
eagues1 reported a series of 60 fetuses with CHB identified
t two centers in Germany between 1989 and 2003 and one
enter in the United States between 1998 and 2003. Fetal
ydrops was the strongest predictor of nonsurvival, fol-
owed by associated complex cardiac malformations, par-
icularly left isomerism (polysplenia). No patient with fetal
ydrops survived past the neonatal period. Taketazu and
olleagues6 recently reported a series of prenatal and post-
atal heterotaxy syndrome cases at The Hospital for Sick
hildren, Toronto, Canada, between 1992 and 2002. There
ere 46 continued pregnancies out of 71 diagnosed fetuses,
4 with right isomerism and 32 with left isomerism. One
etus with right isomerism and 4 with left isomerism had
ssociated CHB; all died in utero or the neonatal period. Our
eam had hoped that a strategy of early dual-chamber pacing
ight change the natural history of these patients, but our
eview has shown this hypothesis not to be correct. The
rognosis remains poor for neonates with CHB and struc-
urally abnormal hearts, particularly heterotaxy syndrome,
ven with early dual-chamber pacing. These findings sug-
est that families should be counseled appropriately, and
ardiac transplant may need to be considered soon after
tabilization with a permanent (or temporary) pacemaker.
In summary, review of our surgical strategy has shown
hat implantation of dual-chamber epicardial pacemakers in
eonates with CHB is technically feasible and yields a
table, long-term pacing system. This was made possible by
he development of steroid-eluting epicardial leads and
maller pacemaker devices. We have had excellent out-
omes and no mortality in patients with structurally normal
earts, and system longevity at 6-year follow-up is excel-
ent. Hence, for the neonate with isolated CHB, early DDD
acing is our procedure of choice. However, neonates
ith CHB associated with heterotaxy syndrome appear to
ave a poor prognosis. In light of our findings, it seems
hat for neonates with CHB and structurally abnormal
earts, stabilization with a pacemaker may be only a
192 The Journal of Thoracic and Cardiovascular Surgery ● Novemporizing procedure with early consideration given to
ardiac transplantation.
ddendum
ince the submission of this article, 2 more neonates (3-day-old,
.7 kg and 1-day-old, 2.5 kg) have had successful placement of
ual-chamber epicardial pacemakers.
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